Bacteriophage and biotechnology in Georgia

Georgia's bacteriophage organizations sit inside a scientifically important ecosystem, but institute history, product identity and commercial authorization are separate evidence questions.

Biochimpharm and Eliava Biopreparations are credible research leads for different reasons. Neither should be reduced to an ordinary catalogue comparison without resolving entity, manufacturing and regulatory boundaries.

What the buyer is deciding

The first decision is what relationship is being evaluated: research collaboration, distribution, licensed medical product, veterinary use or another commercial pathway.

What still needs fieldwork

The reviewed public record does not close product-specific manufacturing authorization, GMP status, clinical claims or destination-market approval.

Companies and processes in this analysis

What this page does not establish

This is a reviewed evidence set, not a market census. A one- or two-company page signals that the category matters to buyers, not that the directory has mapped the full Georgian supplier base. Inclusion does not establish current capacity, commercial interest, regulatory approval or fit for a specific buyer.

First qualification check: Name the exact product, intended use, buyer role and market before requesting the legal manufacturer and current regulatory evidence.